Lv31
260 积分 2021-11-12 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2小时前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Therapeutic Implications of Oncogenic Missense HER2 (ERBB2) Mutations in Gastric Adenocarcinoma
1个月前
已完结
Selective targeting of oncogenic hotspot mutations of the HER2 extracellular domain
1个月前
已完结
Treatment advances in small cell lung cancer (SCLC)
1个月前
已完结
MA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial
1个月前
已关闭
Emerging Strategies for the Treatment of Small Cell Lung Cancer
2个月前
已完结
Recent advances and future strategies in first-line treatment of ES-SCLC
2个月前
已完结
Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report
2个月前
已完结
The importance of tree internal water storage under drought conditions
皖公网安备34019202002308
